CDC is an exchange-traded fund — it holds a basket of underlying assets rather than being a single operating company.
Company fundamentals like P/E, revenue, EPS and profit margins don't apply to a fund — its value comes from the assets it holds, not its own earnings. Use the price chart, options and model forecast below for fund-level analysis.
An institutional-grade, numbers-driven thesis on CDC — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of August 18, 2026, TradersQuant's model rates VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) 50/100 with a 12-month base-case forecast of $57.00 — -26.9% versus the current price of $77.94. VictoryShares US EQ Income Enhanced Volatility Wtd ETF trades at $77.94 in the Financial Services sector, with a market capitalisation of $735.2M. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month analyst consensus price target for CDC is $57.00, implying -26.9% versus the current price. The model's 12-month scenario range runs from $82.79 (bear) to $96.43 (bull), with a base case of $88.64.
CDC currently carries a TradersQuant composite score of 50/100, which we read as a neutral-to-watch signal. Our 12-month price target of $57.00 implies -26.9% from $77.94. This is research, not financial advice — always combine it with your own judgement.
The analyst consensus price target for CDC is $57.00, about -26.9% versus the latest price of $77.94.
TradersQuant's 12-month model forecast for CDC is a base case of $88.64, ranging from $82.79 (bear) to $96.43 (bull), an expected return of +13.7%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for CDC over the next 12 months is $88.64 in the base case (bear $82.79, bull $96.43), versus today's price of $77.94. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for CDC — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates CDC's fair value at $57.00, implying -26.9% of expected upside versus the current price.
VictoryShares US EQ Income Enhanced Volatility Wtd ETF does not currently pay a dividend.
Data and model outputs are for research only and are not financial advice. Figures update continuously.
